SEC Form 4 · accession 0001387131-18-001647
TherapeuticsMD, Inc. · TXMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jane F Barlow
Director
Period of report
Apr 17, 2018
Accepted (ET)
Apr 18, 2018 · 5:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000025743
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $5.72 | Apr 17, 2018 | A | 50,000 | A | Jun 30, 2018 | Apr 17, 2028 | Common Stock | 50,000 | 50,000 | D |